Pricing Agreement

EX-1.2 3 dex12.htm PRICING AGREEMENT Pricing Agreement

Exhibit 1.2

Execution Version

Pricing Agreement

Date: June 13, 2006

Ladies and Gentlemen:

KeyCorp Capital VIII, a statutory trust formed under the laws of the State of Delaware (the “Designated Trust”), and KeyCorp, an Ohio corporation (the “Company”), propose, subject to the terms and conditions stated herein and in the Underwriting Agreement, dated June 13, 2006 (the “Underwriting Agreement”), among the Designated Trust and the Company, on the one hand, and UBS Securities LLC, as Representative of the several underwriters named in Schedule I hereto (the “Underwriters”), on the other hand, to issue and sell to the Underwriters the Securities specified in Schedule II hereto (the “Designated Securities”, consisting of Firm Designated Securities and any Optional Designated Securities the Underwriters may elect to purchase). The principal asset of the Designated Trust consists of debt securities of the Company (the “Junior Subordinated Debentures”), as specified in Schedule II to this Agreement. The Designated Securities will be guaranteed by the Company to the extent set forth in this Agreement with respect to such Designated Securities (the “Guarantee”). Each of the provisions of the Underwriting Agreement is incorporated herein by reference in its entirety, and shall be deemed to be a part of this Agreement to the same extent as if such provisions had been set forth in full herein; and each of the representations and warranties set forth therein shall be deemed to have been made at and as of the Applicable Time set forth in this Pricing Agreement, except that each representation and warranty which refers to the Prospectus in Section 2 of the Underwriting Agreement shall be deemed to be a representation or warranty (i) as of the date of the Underwriting Agreement, (ii) as of the Applicable Time set forth in this Pricing Agreement and (iii) as of the Time of Delivery set forth in this Pricing Agreement. Each reference to the Representative herein and in the provisions of the Underwriting Agreement so incorporated by reference shall be deemed to refer to you. Unless otherwise defined herein, terms defined in the Underwriting Agreement are used herein as therein defined. The Representative designated to act on behalf of the Representatives and on behalf of each of the Underwriters of the Designated Securities pursuant to Section 12 of the Underwriting Agreement and the address of the Representative referred to in such Section 12 are set forth in Schedule II hereto.

An amendment to the Initial Registration Statement or a supplement to the Prospectus, as the case may be, relating to the Designated Securities, and the Issuer Free Writing Prospectus identified on Schedule III hereto, including the documents incorporated therein by reference, in the form heretofore delivered to you is now proposed to be filed with the Commission.

Subject to the terms and conditions set forth herein and in the Underwriting Agreement incorporated herein by reference, the Designated Trust agrees to issue and sell to each of the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the Designated Trust, at the time and place and at the purchase price to the Underwriters set forth in Schedule II hereto, the number of Firm Designated Securities set forth opposite the name of such Underwriter in Schedule I hereto.


If the foregoing is in accordance with your understanding, please sign and return to us seven counterparts hereof, and upon acceptance hereof by you, on behalf of each of the Underwriters, this letter and such acceptance hereof, including the provisions of the Underwriting Agreement incorporated herein by reference, shall constitute a binding agreement between each of the Underwriters and the Designated Trust and the Company. It is understood that your acceptance of this letter on behalf of each of the Underwriters is or will be pursuant to the authority set forth in a form of Agreement among Underwriters, the form of which shall be submitted to the Designated Trust and the Company for examination, upon request, but without warranty on the part of the Representatives as to the authority of the signers thereof.

 

Very truly yours,
KEYCORP
By:  

/s/ Jonathan I. Shulman

Name:   Jonathan I. Shulman
Title:   Senior Vice President
KEYCORP CAPITAL VIII
By:   KeyCorp, as Depositor
By:  

/s/ Jonathan I. Shulman

Name:   Jonathan I. Shulman
Title:   Senior Vice President

 

2


Accepted as of the date hereof:

As Representative of the Underwriters

named in Schedule I hereto

 

UBS SECURITIES LLC
By:  

/s/ Michael Ravanesi

Name:   Michael Ravanesi
Title:   Director
By:  

/s/ Khalid Azim

Name:   Khalid Azim
Title:   Executive Director


SCHEDULE I

 

Underwriter

   Number of
Firm
Designated
Securities
to be
Purchased

UBS Securities LLC

   1,430,000

KeyBanc Capital Markets, a division of McDonald Investments Inc.

   1,430,000

Citigroup Global Markets Inc.

   1,400,000

Merrill Lynch, Pierce, Fenner & Smith Incorporated

   1,400,000

Morgan Stanley & Co. Incorporated

   1,400,000

Wachovia Capital Markets, LLC

   1,400,000

Credit Suisse Securities (USA) LLC

   170,000

Deutsche Bank Securities Inc.

   170,000

Goldman, Sachs & Co.

   170,000

RBC Dain Rauscher Inc.

   170,000

Banc of America Securities LLC

   85,000

Bear, Stearns & Co. Inc.

   85,000

Charles Schwab & Co., Inc.

   85,000

HSBC Securities (USA) Inc.

   85,000

J.P. Morgan Securities Inc.

   85,000

Piper Jaffray & Co.

   85,000

Barclays Capital Inc.

   50,000

D.A. Davidson & Co.

   50,000

Keefe, Bruyette & Woods, Inc.

   50,000

Sandler, O’Neill & Partners, L.P.

   50,000

SBK-Brooks Investment Corp.

   50,000

Stifel, Nicolaus & Company, Incorporated

   50,000

The Williams Capital Group, L.P.

   50,000
    

Total

  
    


SCHEDULE II

Designated Trust:

KeyCorp Capital VIII

Title of Designated Securities:

7% Enhanced Trust Preferred Securities

Aggregate principal amount:

Aggregate Principal Amount of Designated

Securities to be sold: $250,000,000

Price to Public:

100% of the principal amount of the Designated Securities

Purchase Price by Underwriters:

100% of the principal amount of the Designated Securities

Underwriters’ Commission:

$0.7875 per trust preferred security and $7,875,000 in the aggregate, except that the underwriting commission will be $0.50 per trust preferred security with respect to any trust preferred securities sold to institutions. To the extent of those sales, the total underwriting commission will decrease and the net proceeds to the Issuer will increase

Specified Funds for Payment of Purchase Price:

Federal (same day) Funds

Accountants’ Letter to be Delivered on Date of Pricing Agreement:

Yes.

Trust Agreement:

Trust Agreement dated as of April 5, 2005, between the Company and the Trustees named therein, as amended from time to time

 

2


Indenture:

Junior Subordinated Indenture, dated as of December 4, 1996, between the Company and Bankers Trust Company (now known as Deutsche Bank Trust Company Americas), as Indenture Trustee, as supplemented from time to time (the “Indenture”)

Maturity:

Upon the earlier of the stated maturity of the junior subordinated debentures or the earlier redemption of the junior subordinated debentures

Interest Rate:

7% per annum.

Interest Payment Dates:

March 15, June 15, September 15 and December 15

Extension Period:

20 quarters (subject to extension pursuant to the alternative payment mechanism)

Applicable Time:

4:30 p.m., New York City time on June 13, 2006, on the date of this Pricing Agreement.

Time of Delivery:

10:00 a.m., New York City time, on June 20, 2006

Closing Location:

Sullivan & Cromwell LLP

125 Broad Street

New York, New York 10004

Name of Representative:

UBS Securities LLC

299 Park Avenue

New York, New York 10171

 

3


SCHEDULE III

Issuer Free Writing Prospectus

1. The Final Term Sheet dated June 13, 2006